title: Highly active anti-hepatitis C therapy: seven lessons from HIV.
abstract: The HCV direct-acting antiviral treatment era is underway. Although there are some important differences, it is likely that the experience with HCV will be similar in many respects to what already occurred with HIV. This paper considers seven important lessons learned with HIV and the degree to which they should be anticipated with HCV.
authors.affiliation: Johns Hopkins School of Medicine, Baltimore, MD, USA. junk7900@verizon.net
authors.forename: David L
authors.initials: DL
authors.lastname: Thomas
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D024882:Drug Resistance, Viral / Q000187:drug effects*; D014943:Global Health; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology / Q000821:virology; D006801:Humans; D015995:Prevalence; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents